Jazz Pharmaceuticals plc Prepaid Expense, Current
Jazz Pharmaceuticals plc (JAZZ) had Prepaid Expense, Current of $200.00 million as of 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:PrepaidExpenseCurrent · last filed 2026-08-03
- 2026-06-30: Prepaid Expense, Current $200.00M.
- 2026-03-31: Prepaid Expense, Current $149.70M.
- 2025-12-31: Prepaid Expense, Current $152.50M; Prepaid Expense, Current as first filed $152.48M.
- 2025-09-30: Prepaid Expense, Current $146.89M.
| Period end | Prepaid Expense, Current | Prepaid Expense, Current as first filed |
|---|---|---|
| 2026-06-30 | $200.00M 10-Q · filed 2026-08-03 | |
| 2026-03-31 | $149.70M 10-Q · filed 2026-05-05 | |
| 2025-12-31 | $152.50M 10-Q · filed 2026-08-03 | $152.48M 10-K · filed 2026-02-24 |
| 2025-09-30 | $146.89M 10-Q · filed 2025-11-05 | |
| 2025-06-30 | $164.00M 10-Q · filed 2025-08-06 | |
| 2025-03-31 | $150.28M 10-Q · filed 2025-05-07 | |
| 2024-12-31 | $177.41M 10-K · filed 2026-02-24 | |
| 2024-09-30 | $155.13M 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $134.42M 10-Q · filed 2024-08-01 | |
| 2024-03-31 | $122.56M 10-Q · filed 2024-05-02 | |
| 2023-12-31 | $185.48M 10-K · filed 2025-02-26 | |
| 2023-09-30 | $109.99M 10-Q · filed 2023-11-08 | |
| 2023-06-30 | $107.49M 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $72.78M 10-Q · filed 2023-05-10 | |
| 2022-12-31 | $91.91M 10-K · filed 2024-02-28 | |
| 2022-09-30 | $92.88M 10-Q · filed 2022-11-09 | |
| 2022-06-30 | $108.30M 10-Q · filed 2022-08-03 | |
| 2022-03-31 | $117.40M 10-Q · filed 2022-05-04 | |
| 2021-12-31 | $131.41M 10-K · filed 2023-03-01 | |
| 2021-09-30 | $94.47M 10-Q · filed 2021-11-09 | |
| 2021-06-30 | $104.45M 10-Q · filed 2021-08-03 | |
| 2021-03-31 | $57.19M 10-Q · filed 2021-05-04 | |
| 2020-12-31 | $62.42M 10-K · filed 2022-03-01 | |
| 2020-09-30 | $58.30M 10-Q · filed 2020-11-02 | |
| 2020-06-30 | $49.11M 10-Q · filed 2020-08-04 | |
| 2020-03-31 | $38.82M 10-Q · filed 2020-05-05 | |
| 2019-12-31 | $39.43M 10-K · filed 2021-02-23 | |
| 2019-09-30 | $30.84M 10-Q · filed 2019-11-05 | |
| 2019-06-30 | $31.71M 10-Q · filed 2019-08-06 | |
| 2019-03-31 | $28.97M 10-Q · filed 2019-05-07 | |
| 2018-12-31 | $25.02M 10-K · filed 2020-02-25 | |
| 2018-09-30 | $23.19M 10-Q · filed 2018-11-06 | |
| 2018-06-30 | $33.59M 10-Q · filed 2018-08-07 | |
| 2018-03-31 | $27.48M 10-Q · filed 2018-05-08 | |
| 2017-12-31 | $23.18M 10-K · filed 2019-02-26 | |
| 2017-09-30 | $29.25M 10-Q · filed 2017-11-07 | |
| 2017-06-30 | $28.43M 10-Q · filed 2017-08-08 | |
| 2017-03-31 | $38.12M 10-Q · filed 2017-05-09 | |
| 2016-12-31 | $24.50M 10-K · filed 2018-02-27 | |
| 2016-09-30 | $23.30M 10-Q · filed 2016-11-08 | |
| 2016-06-30 | $23.14M 10-Q · filed 2016-08-09 | |
| 2016-03-31 | $18.47M 10-Q · filed 2016-05-10 | |
| 2015-12-31 | $20.70M 10-K · filed 2017-02-28 | |
| 2015-09-30 | $21.27M 10-Q · filed 2015-11-09 | |
| 2015-06-30 | $26.25M 10-Q · filed 2015-08-05 | |
| 2015-03-31 | $27.61M 10-Q · filed 2015-05-07 | |
| 2014-12-31 | $12.80M 10-K · filed 2016-02-23 | |
| 2014-09-30 | $24.21M 10-Q · filed 2014-11-04 | |
| 2014-06-30 | $28.45M 10-Q · filed 2014-08-05 | |
| 2014-03-31 | $14.34M 10-Q · filed 2014-05-08 | |
| 2013-12-31 | $7.18M 10-K · filed 2015-02-24 | |
| 2013-09-30 | $19.35M 10-Q · filed 2013-11-05 | |
| 2013-06-30 | $21.41M 10-Q · filed 2013-08-06 | |
| 2013-03-31 | $11.29M 10-Q · filed 2013-05-07 | |
| 2012-12-31 | $7.45M 10-K · filed 2014-02-25 | |
| 2012-09-30 | $7.13M 10-Q · filed 2012-11-09 | |
| 2012-06-30 | $5.91M 10-Q · filed 2012-08-07 | |
| 2012-03-31 | $5.71M 10-Q · filed 2012-05-08 | |
| 2011-12-31 | $1.69M 10-K · filed 2013-02-26 | |
| 2011-09-30 | $2.54M 10-Q · filed 2011-11-08 | |
| 2011-06-30 | $3.58M 10-Q · filed 2011-08-03 | |
| 2010-12-31 | $1.86M 10-K · filed 2012-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |